MAM
MTV in tie-up with Hutch for interactive show ‘Kya Baat Hai’
MUMBAI: Hutch and MTV Networks India are working together for new interactive chat showKya Baat Hai, billed as a platform for youth across India to express their opinion.
The show kicks off 22 July at 5 pm.
MTV recently launched a slew of interactive shows like Doctor Love, Love Letter, Bol Baby Poll and Ha Ya Na and Kya Baat Hai is the latest in the offering.
The channel will open a discussion on a burning and youth related topic every week. The show will be take place in a Mumbai studio and via satellite simultaneously in Delhi and Bangalore, informs a media release.
Commenting on Hutch’s partnership with MTV, Hutchison Max Telecom operations director Harit Nagpal says, “We see it as an exciting opportunity to create an interactive forum involving audiences in the studio and viewers at home allowing Hutch customers to request for songs, post their views and bid for memorabilia. And all this can be done ‘live’ “.
Kya Baat Ha, hosted by VJ Cyrus Sahukar is in MTV’s trademark wacky style. The show will raise prickly questions like, ‘should smoking be banned in films’, ‘are camera phones being misused – the MMS controversy’, ‘Salman Khan: Hero ya Villain?’, etc.
Those who want to be part of the studio audience can SMS “KBH” to 6882 and keep listening to radio partner 93.5 Red FM.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
